237 related articles for article (PubMed ID: 33413522)
21. Tumor location may affect the clinicopathological features and prognosis of thymomas.
Tian D; Shiiya H; Sato M; Sun CB; Anraku M; Nakajima J
Thorac Cancer; 2019 Nov; 10(11):2096-2105. PubMed ID: 31499597
[TBL] [Abstract][Full Text] [Related]
22. Long-term survival after R0 resection of thymoma.
Koçer B; Kaplan T; Günal N; Koçer BG; Akkaş Y; Yazkan R; Dural K; Kulaçoğlu S; Han S
Asian Cardiovasc Thorac Ann; 2018 Jul; 26(6):461-466. PubMed ID: 29945456
[TBL] [Abstract][Full Text] [Related]
23. [Clinical outcome of epithelial tumors of the thymus].
Tsukada H; Koike J; Osada H
Kyobu Geka; 2002 Oct; 55(11):936-41. PubMed ID: 12391689
[TBL] [Abstract][Full Text] [Related]
24. Surgical effect and prognostic factors of myasthenia gravis with thymomas.
Tian W; Li X; Tong H; Weng W; Yang F; Jiang G; Wang J
Thorac Cancer; 2020 May; 11(5):1288-1296. PubMed ID: 32189468
[TBL] [Abstract][Full Text] [Related]
25. Pathologic radioresponse of preoperatively irradiated invasive thymomas.
Onuki T; Ishikawa S; Yamamoto T; Ito H; Sakai M; Onizuka M; Sakakibara Y; Iijima T; Noguchi M; Ohara K
J Thorac Oncol; 2008 Mar; 3(3):270-6. PubMed ID: 18317070
[TBL] [Abstract][Full Text] [Related]
26. Surgical resection of thymoma still represents the first choice of treatment.
Ried M; Guth H; Potzger T; Diez C; Neu R; Schalke B; Hofmann HS
Thorac Cardiovasc Surg; 2012 Mar; 60(2):145-9. PubMed ID: 21692020
[TBL] [Abstract][Full Text] [Related]
27. Outcome of multimodality treatment for 188 cases of type B3 thymoma.
Gao L; Wang C; Fang W; Zhang J; Lv C; Fu S
J Thorac Oncol; 2013 Oct; 8(10):1329-34. PubMed ID: 24457243
[TBL] [Abstract][Full Text] [Related]
28. [Correlations of novel histological classification of 82 thymoma patients to their clinical characteristics and prognosis].
Su XD; Rong TH; Long H; He JH; Zhang LJ; Zhang X; Zhao JM
Ai Zheng; 2005 Nov; 24(11):1363-6. PubMed ID: 16552964
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up.
Lucchi M; Melfi F; Dini P; Basolo F; Viti A; Givigliano F; Angeletti CA; Mussi A
J Thorac Oncol; 2006 May; 1(4):308-13. PubMed ID: 17409875
[TBL] [Abstract][Full Text] [Related]
30. Predictors of recurrence after thymoma resection.
Bae MK; Lee CY; Lee JG; Park IK; Kim DJ; Yang WI; Chung KY
Yonsei Med J; 2013 Jul; 54(4):875-82. PubMed ID: 23709420
[TBL] [Abstract][Full Text] [Related]
31. Unradical Surgery for Locally-Advanced Thymoma: Is it time to evolve Perspectives?
Mastromarino MG; Bacchin D; Aprile V; Ceccarelli I; Korasidis S; Lenzini A; Ambrogi MC; Lucchi M
Lung Cancer; 2023 Jun; 180():107214. PubMed ID: 37104878
[TBL] [Abstract][Full Text] [Related]
32. The role of a pseudocapsula in thymic epithelial tumors: outcome and correlation with established prognostic parameters. Results of a 20-year single centre retrospective analysis.
Dango S; Passlick B; Thiemann U; Kayser G; Stremmel C
J Cardiothorac Surg; 2009 Jul; 4():33. PubMed ID: 19604398
[TBL] [Abstract][Full Text] [Related]
33. Expression of podoplanin in thymoma: its correlation with tumor invasion, nodal metastasis, and poor clinical outcome.
Tateyama H; Sugiura H; Yamatani C; Yano M
Hum Pathol; 2011 Apr; 42(4):533-40. PubMed ID: 21237498
[TBL] [Abstract][Full Text] [Related]
34. Thymoma. Analysis of prognostic factors.
Sonobe M; Nakagawa M; Ichinose M; Ikegami N; Nagasawa M; Shindo T
Jpn J Thorac Cardiovasc Surg; 2001 Jan; 49(1):35-41. PubMed ID: 11233240
[TBL] [Abstract][Full Text] [Related]
35. Association of thymoma and myasthenia gravis: oncological and neurological results of the surgical treatment.
Lucchi M; Ricciardi R; Melfi F; Duranti L; Basolo F; Palmiero G; Murri L; Mussi A
Eur J Cardiothorac Surg; 2009 May; 35(5):812-6; discussion 816. PubMed ID: 19237289
[TBL] [Abstract][Full Text] [Related]
36. Analysis of surgical treatment of Masaoka stage III-IV thymic epithelial tumors.
Hamanaka K; Koyama T; Matsuoka S; Takeda T; Miura K; Yamada K; Hyogotani A; Seto T; Okada K; Ito KI
Gen Thorac Cardiovasc Surg; 2018 Dec; 66(12):731-735. PubMed ID: 30132223
[TBL] [Abstract][Full Text] [Related]
37. World Health Organization histologic classification: an independent prognostic factor in resected thymomas.
Rena O; Papalia E; Maggi G; Oliaro A; Ruffini E; Filosso P; Mancuso M; Novero D; Casadio C
Lung Cancer; 2005 Oct; 50(1):59-66. PubMed ID: 16009453
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors after treatment for iterative thymoma recurrences: A multicentric experience.
Chiappetta M; Zanfrini E; Giraldi L; Mastromarino MG; Petracca-Ciavarella L; Nachira D; Congedo MT; Aprile V; Ambrogi MC; Lucchi M; Filosso PL; Ruffini E; Guerrera F; Mulè A; Alì G; Molinaro L; Lococo F; Meacci E; Margaritora S
Lung Cancer; 2019 Dec; 138():27-34. PubMed ID: 31606522
[TBL] [Abstract][Full Text] [Related]
39. [The relationship between myasthenia gravis and the different pathological type of thymoma patients' operation and prognosis].
Zhang Y; Yu L; Jing Y; Ke J
Zhonghua Wai Ke Za Zhi; 2015 Aug; 53(8):612-6. PubMed ID: 26653963
[TBL] [Abstract][Full Text] [Related]
40. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer.
Mornex F; Resbeut M; Richaud P; Jung GM; Mirabel X; Marchal C; Lagrange JL; Rambert P; Chaplain G; Nguyen TD
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):651-9. PubMed ID: 7790251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
